Clinical Trial Update: GALENOS 1 in Head and Neck, Lung, and Rectal Cancer Patients

View source ↗

Summary

The GALENOS 1 trial is currently recruiting for patients with head and neck squamous cell carcinoma, locally advanced rectal cancer, and lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Lung Cancer
• Rectal Cancer

Snippet

Sponsor: Fondazione del Piemonte per l'Oncologia | Conditions: Head and Neck Squamous Cell Carcinoma, Locally Advanced Rectal Cancer | Status: RECRUITING